An impressive 45% of fibromyalgia patients have achieved ... Trying to find help and new treatment options through specialists turned out to be a dead end, and it wasn’t until her Beaconsfield ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

This development could mark the introduction of the first new drug for fibromyalgia in over 15 years, addressing the needs of more than 10 million adults in the U.S. affected by this chronic pain ...

Fibromyalgia, the chronic pain condition that plagues approximately ten million Americans is in need of new drug treatment options. The existing approved drugs on the market often aren't enough.

Dr. Lederman continued, "Most fibromyalgia patients report dissatisfaction with current drug treatment options. If approved by the FDA, we expect TNX-102 SL to become the first new drug for ...

Fibromyalgia sufferers around the world are in need of relief. Tonix is hoping that a new treatment option may soon be available. Tonix Pharmaceuticals awaits the FDA decision on NDA acceptance ...

Growing awareness about fibromyalgia and advancements in treatment options drive market growth. Generic Medication Accessibility: Enhanced availability of generic medications for fibromyalgia ...

“The fibromyalgia community, comprised of patients and their families and support groups, has been waiting for a new drug for over 15 years. Analysis of insurance claims in the U.S ...